Zobrazeno 1 - 10
of 56
pro vyhledávání: '"J.C. van Denderen"'
Autor:
M Baniaamam, I C van Eijk, J.C. van Denderen, M. T. Nurmohamed, Mike J L Peters, I E van der Horst-Bruinsma, I A M van den Oever, Suat Simsek, Yvo M. Smulders, H G Raterman
Publikováno v:
Rheumatology International, 41, 2, pp. 319-328
Rheumatology International, 41, 319-328
Rheumatology International, 41(2), 319-328. Springer Verlag
van den Oever, I A M, Baniaamam, M, Simsek, S, Raterman, H G, van Denderen, J C, van Eijk, I C, Peters, M J L, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2021, ' The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis ', Rheumatology International, vol. 41, no. 2, pp. 319-328 . https://doi.org/10.1007/s00296-020-04666-6
Rheumatology International
Rheumatology International, 41, 319-328
Rheumatology International, 41(2), 319-328. Springer Verlag
van den Oever, I A M, Baniaamam, M, Simsek, S, Raterman, H G, van Denderen, J C, van Eijk, I C, Peters, M J L, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2021, ' The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis ', Rheumatology International, vol. 41, no. 2, pp. 319-328 . https://doi.org/10.1007/s00296-020-04666-6
Rheumatology International
Given the link between systemic inflammation, body composition and insulin resistance (IR), anti-inflammatory therapy may improve IR and body composition in inflammatory joint diseases. This study assesses the IR and beta cell function in rheumatoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7932f3f429885050ef45dd8a6c8fe7
https://repository.ubn.ru.nl/handle/2066/244713
https://repository.ubn.ru.nl/handle/2066/244713
Autor:
L. Burgemeister, J.C. van Denderen, G.J. Wolbink, A W R van Kuijk, Merel J l'Ami, Femke Hooijberg, C. Krieckaert, E. Kneepkens, Michael T. Nurmohamed, J. Ruwaard, Maarten Boers
Publikováno v:
Annals of the Rheumatic Diseases. 79:130-130
Background:The majority of patients with a rheumatic disease treated with etanercept may be overexposed. Data regarding etanercept tapering is scarce, particularly in psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Dose reductions can pote
Autor:
V. P. Van Halm, Otto Kamp, S. C. Heslinga, M. Baniaamam, J.C. van Denderen, M. L. Handoko, Laura Boekel, M. T. Nurmohamed, I. Van der Horst-Bruinsma, T. C. Konings
Publikováno v:
Annals of the Rheumatic Diseases. 79:744.2-744
Background:The overall mortality rate in ankylosing spondylitis (AS) patients is increased by 60–90% compared with the general population. This higher mortality rate is predominately caused by cardiovascular disease (CVD) comprising an increased pr
Autor:
Michael T. Nurmohamed, J.C. van Denderen, Merel J l'Ami, Gertjan Wolbink, J. Ruwaard, E. Kneepkens, AF Marsman, I E van der Horst-Bruinsma
Publikováno v:
Ruwaard, J, l’Ami, M, Marsman, A, Kneepkens, E, van Denderen, J, van der Horst-Bruinsma, I, Nurmohamed, M & Wolbink, G 2018, ' Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab ', Scandinavian Journal of Rheumatology, vol. 47, no. 2, pp. 122-126 . https://doi.org/10.1080/03009742.2017.1330419
Scandinavian Journal of Rheumatology, 47(2), 122-126. Informa Healthcare
Scandinavian journal of rheumatology, 47(2), 122-126. Informa Healthcare
Scandinavian Journal of Rheumatology, 47(2), 122-126. Informa Healthcare
Scandinavian journal of rheumatology, 47(2), 122-126. Informa Healthcare
Objective: To compare rates of drug survival and clinical response during 2 years of follow-up in ankylosing spondylitis (AS) patients treated with etanercept or adalimumab in routine care. Method: Biological-naïve consecutive AS patients treated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f0c69332dc7c78d23aa8d84bb59680
https://research.vumc.nl/en/publications/e29616fc-97ce-4d0e-95e9-f5ea9c7dc23e
https://research.vumc.nl/en/publications/e29616fc-97ce-4d0e-95e9-f5ea9c7dc23e
Autor:
Maria Konsta, Michael T. Nurmohamed, J.C. van Denderen, I E van der Horst-Bruinsma, Alexios Iliopoulos, P.P. Sfikakis, I.M. Visman
Publikováno v:
Poster Presentations.
Background Although there is debate whether treatment with TNF inhibitors (TNFi) in AS may not inhibit spinal radiographic progression, the effect on hip involvement may be different (1,2). Objectives To estimate the impact of long-term TNFi treatmen
Autor:
Ie der horst-Bruinsma van, SE Ibáñez Vodnizza, Michael T. Nurmohamed, J.C. van Denderen, W.F. Lems, I.M. Visman
Publikováno v:
Poster Presentations.
Background Women with Ankylosing Spondylitis (AS) seem to be less responsive to TNF-α blockers and have a shorter drug survival. This might be explained by differences in body composition (BC), as women have higher total body fat (BF). Objectives As
Autor:
Michael T. Nurmohamed, J.C. van Denderen, Alexios Iliopoulos, P.P. Sfikakis, I.M. Visman, Maria Konsta, I E van der Horst-Bruinsma
Publikováno v:
Poster Presentations.
Background Hip involvement is the most frequent extraspinal arthritic manifestation of Ankylosing Spondylitis (AS) and a common cause of disability. It is present in 24% to 36% of AS patients, leading to total hip replacement (THR) in 5%. Objectives
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M.W. Heijmans, I.E. Bruinsma, M.A.C. van der Weijden, B A C Dijkmans, J.C. van Denderen, Willem F. Lems
Publikováno v:
van der Weijden, M A C, van der Horst-Bruinsma, I E, van Denderen, J C, Dijkmans, B A C, Heijmans, M W & Lems, W F 2010, ' High Frequency of Vertebral Fractures in Early Spondylarthropathies ', Clinical and Experimental Rheumatology, vol. 28, no. 4, pp. 629-629 .
Clinical and Experimental Rheumatology, 28(4), 629-629. Clinical and Experimental Rheumatology S.A.S.
van der Weijden, M A C, Bruinsma, I E, van Denderen, J C, Dijkmans, B A C, Heijmans, M W & Lems, W F 2012, ' High frequency of vertebral fractures in early spondylarthropathies ', Osteoporosis International, vol. 23, no. 6, pp. 1683-1690 . https://doi.org/10.1007/s00198-011-1766-z
Osteoporosis International, 23(6), 1683-1690. Springer London
Clinical and Experimental Rheumatology, 28(4), 629-629. Clinical and Experimental Rheumatology S.A.S.
van der Weijden, M A C, Bruinsma, I E, van Denderen, J C, Dijkmans, B A C, Heijmans, M W & Lems, W F 2012, ' High frequency of vertebral fractures in early spondylarthropathies ', Osteoporosis International, vol. 23, no. 6, pp. 1683-1690 . https://doi.org/10.1007/s00198-011-1766-z
Osteoporosis International, 23(6), 1683-1690. Springer London
Summary We demonstrated that vertebral fractures (VF) are commonly found in early SpA. Patients with VF had lower lumbar BMD than patients without VF. VF remained frequently 'unrecognized' and untreated. VF have been associated with more back pain, r
Autor:
M.A.C. van der Weijden, Willem F. Lems, J.C. van Denderen, I E van der Horst-Bruinsma, Martijn W. Heymans, Ben A. C. Dijkmans
Publikováno v:
van der Weijden, M A C, van Denderen, J C, Lems, W F, Heijmans, M W, Dijkmans, B A C & van der Horst-Bruinsma, I E 2011, ' Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies ', Clinical Rheumatology, vol. 30, no. 4, pp. 497-503 . https://doi.org/10.1007/s10067-010-1538-8
Clinical Rheumatology, 30(4), 497-503. Springer London
Clinical Rheumatology
Clinical Rheumatology, 30(4), 497-503. Springer London
Clinical Rheumatology
The objective of this study was to determine the prevalence and risk factors of low bone mineral density (BMD) in patients with spondylarthropathies (SpA) at an early stage of disease. In this cross-sectional study, the BMD of lumbar spine and hips w